Methyldopa: A Comprehensive Clinical Overview
Methyldopa is a centrally acting antihypertensive agent used primarily in the management of elevated blood pressure, with a notable emphasis on its safety profile during pregnancy. It is metabolised into alpha-methyl norepinephrine within the central nervous system (CNS), where it activates central alpha-2 adrenergic receptors. This action reduces sympathetic outflow, thereby decreasing peripheral vascular resistance and lowering blood pressure. Structurally similar to L-DOPA, methyldopa holds historical significance as one of the earliest central antihypertensives and remains clinically relevant today due to its safety in specific populations.
![]() |
| Image source Google |













.webp)




.jpeg)
.jpeg)
